Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approv …

biogens controversial alzheimers drug generates 2 million in first few weeks after approval

Sumary of Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approval:

  • Biogen’s top research chief Dr. Al Sandrock defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close